Pyxis Oncology, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Boston, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Pyxis Oncology, Inc. has filed 342 SEC EDGAR filings since 12 Jul 2019

SEC filing history

Showing 301-325 of 342 matching filings.

Per page
25
Current page
13
4

FORM 4

Filing date
12 Oct 2021
Reporting date
07 Oct 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
12 Oct 2021
Reporting date
07 Oct 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
12 Oct 2021
Reporting date
07 Oct 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
12 Oct 2021
Reporting date
07 Oct 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
12 Oct 2021
Reporting date
07 Oct 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
12 Oct 2021
Reporting date
07 Oct 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
12 Oct 2021
Reporting date
07 Oct 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
424B4 File 333-259627

424B4

Filing date
08 Oct 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-259627

EFFECT filing

Filing date
07 Oct 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1MEF File 333-260127

S-1MEF

Filing date
07 Oct 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
07 Oct 2021
Reporting date
07 Oct 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
07 Oct 2021
Reporting date
07 Oct 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
07 Oct 2021
Reporting date
07 Oct 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
07 Oct 2021
Reporting date
07 Oct 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
3

PRIMARY DOCUMENT

Filing date
07 Oct 2021
Reporting date
07 Oct 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
07 Oct 2021
Reporting date
07 Oct 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
07 Oct 2021
Reporting date
07 Oct 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
07 Oct 2021
Reporting date
07 Oct 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
07 Oct 2021
Reporting date
07 Oct 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
07 Oct 2021
Reporting date
07 Oct 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
07 Oct 2021
Reporting date
07 Oct 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
SEC STAFF LETTER

SEC STAFF LETTER filing

Filing date
07 Oct 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
07 Oct 2021
Reporting date
07 Oct 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1/A File 333-259627

S-1/A

Filing date
07 Oct 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CERT File 001-40881

CERT filing

Filing date
06 Oct 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .